4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2

CompletedOBSERVATIONAL
Enrollment

293

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

February 28, 2024

Study Completion Date

February 28, 2024

Conditions
Corticobasal Degeneration (CBD)Corticobasal Syndrome (CBS)Cortical-basal Ganglionic Degeneration (CBGD)Progressive Supranuclear Palsy (PSP)Nonfluent Variant Primary Progressive Aphasia (nfvPPA)Oligosymptomatic/Variant Progressive Supranuclear Palsy (o/vPSP)
Interventions
OTHER

Observational Study

Trial Locations (8)

10032

Columbia University, New York

19104

University of Pennsylvania, Philadelphia

21287

Johns Hopkins University, Baltimore

55905

Mayo Clinic - Rochester, Rochester

92037

University of California, San Diego (UCSD), San Diego

94158

University of California, San Francisco (UCSF), San Francisco

02129

Harvard University - Massachusetts General Hospital, Charlestown

M5T 2S8

University of Toronto, Toronto

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Aging (NIA)

NIH

lead

University of California, San Francisco

OTHER

NCT02966145 - 4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2 | Biotech Hunter | Biotech Hunter